Gene Query: DPPA4

Dataset Description Geneva Score
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 95.32
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 83.95
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 69.4
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 64.05
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 64.04
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 63.27
Cerebellar differentiation in Ataxia-Telangiectasia 55.88
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 51.85
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 49.95
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 49.95
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 49.6
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 49.44
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 47.01
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 46.65
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 45.01
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 45.01
miR-93 Targets in Human Endothelial Cells 44.22
Transcriptome analysis of H9 hESC derived cerebral organoids 44.09
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 43.86
Differentially expressed vascular development genes for iPSC-ECs from CDI 41.44
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 41.24
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 41.24
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 40.79
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 39.74
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 39.58
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 38.25
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 37.95
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 37.91
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 37.91
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 37.8
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 37.08
Examining serotonergic neuron differentiation from human iPSCs 36.51
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 35.09
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 35.04
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 35.02
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 35.02
RNA-Seq from early time points in the kidney differentiation protocol 34.92
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 34.69
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 33.43
Characterization of the Merkel cell carcinoma miRNome 32.78
High-efficiency RNA-based reprogramming of human primary fibroblasts 32.56
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 32.42
High level DNA repair gene expression in human ES cells 30.96
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 30.73
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 30.39
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 30.38
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 30.38
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 30.17
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 29.96
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 29.62
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 29.25
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 29.12
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 28.94
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 28.9
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 28.61
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 28.61
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 28.49
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 28.09
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 28.09
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 27.53
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 27.37
Mechanistic Model-Guided Study of Embryonic Morphogenesis 27.36
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 27.29
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 26.79
Accurate annotation of human protein-coding small open reading frames 26.77
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 26.75
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 26.75
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 26.6
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 26.57
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 26.13
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 26.03
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 26.0
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 25.73
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 25.04
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 25.01
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 25.01
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 24.87
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 24.37
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 24.14
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 23.63
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 23.56
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 23.44
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 23.44
MARS Seq data from human cortical organoids 23.04
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 22.53
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 22.52
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 22.46
Dynamic reorganization of nuclear architecture during human cardiogenesis 22.37
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 22.37
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 22.37
MEIS1 regulates hematopoiesis in hPSCs 22.26
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 22.26
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 22.13
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 22.11
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 21.97
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 21.97
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 21.68
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 21.63
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 21.59
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 21.45
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 21.31
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 21.31
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 21.16
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 21.11
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 21.0
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 21.0
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 20.85
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 20.85
iPSC-Derived Cholangiocytes 20.78
Next generation sequencing of small RNAs isolated from exosomes in human semen 20.47
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 20.46
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 20.13
Alteration of the microRNA network during the progression of Alzheimer’s disease 19.89
19.87
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 19.42
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 19.32
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 18.62
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 18.6
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 18.6
The comparison of high-throughput single-cell RNA-seq methods 18.27
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 18.18
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 17.54
Ectoderm specification of H1 human embryonic stem cells 17.54
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 17.52
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 16.99
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 16.96
Next Generation Sequencing of human SMA and healthy control Motor Neurons 16.84
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 16.51
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 16.47
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 15.97
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 15.97
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 15.75
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 15.75
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 15.72
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 15.72
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 15.7
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 15.55
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 15.51
Postnatal lipids drive hepatocyte maturation 15.47
Epigenome regulation during epidermal lineage commitment [RNA-seq] 15.11
Engineering Patient-Specific Tissue Implants 14.64
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 14.56
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 14.45
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 14.37
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 14.37
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 14.3
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 14.2
Regionally specified human pluripotent stem cell-derived astrocytes 13.99
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 13.82
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 13.57
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 13.57
Sensing self and nonself circular RNAs 13.56
RNA sequencing analysis of human embryonic stem cells and axial progenitors 13.52
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 13.33
Transcriptome analysis of kidney organoids 13.2
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 13.14
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 13.14
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 13.13
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 13.12
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 12.95
mRNA-Seq profiling of human developing kidney 12.91
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 12.8
PNET animal model: new insights (II) 12.76
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 12.39
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 12.39
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 12.31
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 12.28
Single-Cell Genotyping of Transcriptomes 12.2
RNA-seq of Single-Cell Genotyping of Transcriptomes 12.2
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 12.08
FGF2 regulation of gene expression in stable inducible Neurons 12.06
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 11.94
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 11.83
Regulatory network controlling tumor-promoting inflammation in human cancers 11.83
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 11.8
Peptidomimetic blockade of MYB in acute myeloid leukemia 11.79
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 11.79
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 11.7
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 11.7
Single-nucleotide-resolution mapping of HBV promoters using CAGE 11.59
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 11.58
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 11.54
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 11.4
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 11.31
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 11.26
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 11.19
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 11.17
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 11.04
T47D RNA-seq and ChrRNA-seq data 11.04
High-throughput sequencing of PROMPT-enriched samples. 11.03
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 10.78
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 10.61
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 10.49
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 10.49
Identification of Atrial Fibrillation associated genes and functional non-coding variants 10.48
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 10.48
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 10.25
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 10.25
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 10.16
Reassessment of Exosome Composition 10.1
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 10.06
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 9.99
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 9.91
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 9.85
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 9.81
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 9.79
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 9.77
Derivation and differentiation of haploid human embryonic stem cells 9.73
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 9.5
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 9.47
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 9.44
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 9.44
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 9.42
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 9.38
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 9.34
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 9.34
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 9.18
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 9.18
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 9.14
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 9.12
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 9.04
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 8.91
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 8.91
Molecular Mechanisms of Endothelial Hyperpermeability 8.88
Generating Patterned Kidney Organoids for Studying Development and Diseases 8.78
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 8.75
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 8.71
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 8.71
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 8.57
Human neutrophil genome during PMA- and E. coli encounter-induced activation 8.56
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 8.56
RNA-seq analysis of RALD iPSCs after in vitro differentiation 8.45
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 8.34
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 8.34
Direct Isolation and Characterization of Human Nephron Progenitors. 8.34
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 8.27
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 8.14
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 8.12
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 8.11
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 7.84
Zika infected neural stem cells 7.8
Transcriptome analysis of Zika infected neural stem cells 7.8
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 7.8
The role of m6A/m-RNA methylation in stress response regulation 7.7
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 7.7
Modeling Familial Cancer with iPSC Approaches 7.57
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 7.54
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 7.41
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 7.4
RNA-sequencing 7.37
Cleavage Factor Im as a key regulator of 3’ UTR length 7.23
CD95/Fas ligand mRNA is toxic to cells 7.11
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 7.1
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 7.08
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 7.08
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 7.04
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 6.93
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 6.93
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 6.87
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 6.87
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 6.82
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 6.74
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 6.72
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 6.66
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 6.65
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 6.63
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 6.56
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 6.52
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 6.52
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 6.52
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 6.52
BI Human Reference Epigenome Mapping Project 6.5
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 6.4
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 6.38
Differential Protein Occupancy Profiling of the mRNA Transcriptome 6.33
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 6.26
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 6.21
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 6.21
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 6.18
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.1
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 6.07
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 6.03
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 6.03
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.03
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 6.0
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 5.99
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 5.99
Global expression profiles in cardiac progenitor cells generated by ISX-9 5.96
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 5.96
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 5.87
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 5.79
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 5.53
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 5.52
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 5.47
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 5.41
HNF1A deficiency impairs β-cell fate, granule maturation and function 5.4
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 5.33
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 5.15
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 5.12
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 5.02
Functional astrocytes differentiated from hiPSCs 4.98
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 4.98
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 4.94
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 4.94
The role of CFTR in islet function 4.91
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 4.85
Gene expression profile of human iPSC-derived nephron progenitor cells 4.84
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.78
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.78
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 4.77
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 4.73
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 4.72
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 4.64
METTL3 and WTAP 4.63
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 4.63
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 4.61
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 4.6
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 4.57
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 4.54
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 4.53
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 4.52
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 4.51
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 4.51
Human Tfh cell RNA bulk sequencing 4.47
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 4.44
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 4.41
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 4.41
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 4.4
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 4.39
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 4.36
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 4.36
Epigenome regulation during epidermal lineage commitment 4.36
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 4.32
scRNASeq analysis of cycling cardiomyocytes 4.27
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.25
Bone marrow derived human B cells [normal proB] 4.18
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 4.17
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 4.14
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 4.11
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.09
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 4.08
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 4.08
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 4.06
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 4.06
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 4.02
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 3.98
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 3.94
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 3.86
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 3.84
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 3.81
Age-Related Gene Expression Changes in Prostate Cancer Patients 3.74
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 3.74
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 3.72
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 3.66
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.65
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 3.65
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 3.65
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 3.65
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 3.62
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 3.62
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 3.6
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.6
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 3.6
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 3.38
Dissecting neural differentiation regulatory networks through epigenetic footprinting 3.34
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 3.34
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 3.29
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 3.29
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 3.25
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 3.22
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 3.21
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.2
RNA-seq melanoma 3.14
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 3.14
Gene expression of collecting duct carcinoma of the kidney 3.12
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.03
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 3.01
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 3.01
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 2.96
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 2.94
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 2.94
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 2.9
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 2.86
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.79
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 2.77
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.75
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.73
A single cell reference map for human blood and tissue T cell activation 2.7
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 2.69
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 2.69
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.61
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 2.54
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.52
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.5
Dynamic 3D chromosomal landscapes in acute leukemia 2.5
Patient-derived xenograft platform for metastatic melanoma 2.49
hESC neural differentiation 2.49
RNA-seq analysis of gene expression patterns during hESC neural differentiation 2.49
Exploring the RNA landscape of endothelial exosomes 2.47
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 2.46
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 2.46
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 2.44
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.44
Single-cell analysis of human kidney organoids 2.38
Transcriptome of EBV-infected gastric cancer cell lines 2.35
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.32
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 2.23
Metastasis in triple-negative breast cancer 2.21
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.21
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 2.13
Microglia innatly develop within cerebral organoids 2.1
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.98
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.97
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 1.97
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.89
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.87
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.87
Interphase condensins regulate ligand-depedent enhancer activation 1.86
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.86
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 1.82
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.76
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.74
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 1.74
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.73
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 1.73
RNA polymerase in pre-B-ALL cell lines 1.7
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.69
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.69
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.67
Toxoplasma gondii infection of human retinal pigment epithelial cells 1.65
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 1.64
RNA-seq of CD33 KO and control HSPCs 1.63
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.63
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 1.62
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.6
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.6
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.56
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.53
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.52
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.52
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 1.51
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.5
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.47
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.44
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 1.44
Genome-wide Analysis of Chromatin Interactions in Human Cells 1.43
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.41
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 1.39
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.39
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 1.39
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.33
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.27
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.24
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.24
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 1.2
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 1.14
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 1.07
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.06
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 1.01
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.97
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.95
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.93
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 0.81
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 0.8
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.78
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 0.75
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 0.75
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.72
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.72
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.72
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.71
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 0.59
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.55
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.53
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.49
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.49
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.46
A single-cell transcriptome atlas of the human pancreas 0.45
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.41
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.4
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 0.4
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 0.4
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.4
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.37
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.35
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 0.34
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.26
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.26
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.26
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.23
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.2
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.2
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.2
hNSCs siRNA NOVA2 0.16
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.15
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.13
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.11
The transcriptome of Kawasaki Disease arteritis 0.08
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.01
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation